Procter & Gamble (NYSE:PG – Get Free Report) will be posting its quarterly earnings results before the market opens on Friday, October 18th. Analysts expect Procter & Gamble to post earnings of $1.90 per share for the quarter. Procter & Gamble has set its FY 2025 guidance at 6.910-7.050 EPS and its FY25 guidance at $6.91-7.05 EPS.Persons that are interested in registering for the company’s earnings conference call can do so using this link.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same period in the previous year, the firm posted $1.37 EPS. The business’s revenue for the quarter was down .1% compared to the same quarter last year. On average, analysts expect Procter & Gamble to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.
Procter & Gamble Stock Performance
Shares of Procter & Gamble stock opened at $173.61 on Wednesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The business’s 50 day moving average price is $171.68 and its 200 day moving average price is $166.96. The company has a market cap of $409.74 billion, a price-to-earnings ratio of 28.37, a PEG ratio of 3.67 and a beta of 0.41. Procter & Gamble has a one year low of $142.50 and a one year high of $177.94.
Procter & Gamble Dividend Announcement
Analyst Ratings Changes
A number of analysts have recently issued reports on PG shares. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. DA Davidson reaffirmed a “neutral” rating and issued a $159.00 price target on shares of Procter & Gamble in a research note on Tuesday. Royal Bank of Canada raised their price objective on Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research report on Wednesday, July 31st. Piper Sandler initiated coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price on the stock. Finally, Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research report on Monday, September 30th. Nine equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $176.21.
Get Our Latest Report on Procter & Gamble
Insiders Place Their Bets
In other news, insider Susan Street Whaley sold 634 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the transaction, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 383,194 shares of company stock worth $65,140,718 in the last 90 days. Corporate insiders own 0.17% of the company’s stock.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Why Are These Companies Considered Blue Chips?
- AMD Gains Momentum With AI: Can It Beat Expectations?
- When to Sell a Stock for Profit or Loss
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.